Further studies on the specificity of proglumide as a selective cholecystokinin antagonist in the central nervous system.
Bunney
B S
BS
Chiodo
L A
LA
Freeman
A S
AS
D000818:Animals; D000856:Anorexia Nervosa / Q000188:drug therapy; D014150:Antipsychotic Agents / Q000494:pharmacology; D001058:Apomorphine / Q000494:pharmacology; D001921:Brain / Q000187:drug effects*; D002766:Cholecystokinin / Q000032:analysis / Q000037:antagonists & inhibitors* / Q000494:pharmacology; D005973:Glutamine / Q000031:analogs & derivatives*; D006801:Humans; D008636:Mesencephalon / Q000187:drug effects; D009474:Neurons / Q000187:drug effects; D011377:Proglumide / Q000494:pharmacology*; D011954:Receptors, Dopamine / Q000032:analysis / Q000187:drug effects; D012559:Schizophrenia / Q000188:drug therapy
D014150:Antipsychotic Agents; D011954:Receptors, Dopamine; D005973:Glutamine; D002766:Cholecystokinin; D011377:Proglumide; D001058:Apomorphine